Investigation Overview
July 20, 2015 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Receptos Inc (NASDAQ:RCPT), was announced concerning whether the takeover of Receptos by Celgene Corporation for $232.00 per share is unfair to NASDAQ:RCPT stockholders. The investigation by a law firm concerns whether certain officers and directors of Receptos Inc breached...
You must register (for free) or login to view the entire investigation.